Comparing the economic terms of biotechnology licenses from academic institutions with those between commercial firms von Shah, Prateet, Vaughan, Gregory, Ledley, Fred D

Volltext

NIH funding for patents that contribute to market exclusivity of drugs approved 2010-2019 and the public interest protections of Bayh-Dole von Ledley, Fred D, Cleary, Ekaterina Galkina

Volltext

Timelines of translational science: From technology initiation to FDA approval von McNamee, Laura M, Walsh, Michael Jay, Ledley, Fred D

Volltext

Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration, 2010–2019: a cross-sectional ana... von Jackson, Matthew J, Vaughan, Gregory, Ledley, Fred D

Volltext

Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016 von Cleary, Ekaterina Galkina, McNamee, Laura M., de Boer, Skyler, Holden, Jeremy, Fitzgerald, Liam, Ledley, Fred D.

Volltext

Modeling timelines for translational science in cancer; the impact of technological maturation von McNamee, Laura M, Ledley, Fred D

Volltext

Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies von Ledley, Fred D, McCoy, Sarah Shonka, Vaughan, Gregory, Cleary, Ekaterina Galkina

Volltext

As Technologies for Nucleotide Therapeutics Mature, Products Emerge von Beierlein, Jennifer M., McNamee, Laura M., Ledley, Fred D.

Volltext

Contribution of NIH funding to new drug approvals 2010–2016 von Cleary, Ekaterina Galkina, Beierlein, Jennifer M., Khanuja, Navleen Surjit, McNamee, Laura M., Ledley, Fred D.

Volltext

Modeling impact of inflation reduction act price negotiations on new drug pipeline considering differential contributions of large and small biopharmaceutical companies von Vaughan, Gregory, Du, Roger, Ledley, Fred D

Volltext

Methods Used to Assess Pharmaceutical Research and Development Costs von Ledley, Fred D

Volltext

Patterns of Innovation in Alzheimer’s Disease Drug Development: A Strategic Assessment Based on Technological Maturity von Beierlein, Jennifer M., PhD, McNamee, Laura M., PhD, Walsh, Michael J., PhD, Ledley, Fred D., MD

Volltext

NIH funding for vaccine readiness before the COVID-19 pandemic von Kiszewski, Anthony E., Cleary, Ekaterina Galkina, Jackson, Matthew J., Ledley, Fred D.

Volltext

We Don't Have to Lose STEM Students to Business von Wernick, Naomi L B, Ledley, Fred D

Volltext

NIH funding for research underlying new cancer therapies von Cleary, Ekaterina Galkina, Ledley, Fred D

Volltext

Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997–2016 von McNamee, Laura M., Cleary, Ekaterina Galkina, Zhang, Sunyi, Salim, Usama, Ledley, Fred D.

Volltext

Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry von Zhou, Edward W, Jackson, Matthew J, Ledley, Fred D

Volltext

Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019 von Galkina Cleary, Ekaterina, Jackson, Matthew J, Zhou, Edward W, Ledley, Fred D

Volltext

Patterns of technological innovation in biotech von McNamee, Laura M, Ledley, Fred D

Volltext

Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities von Beierlein, Jennifer M., McNamee, Laura M., Walsh, Michael J., Kaitin, Kenneth I., DiMasi, Joseph A., Ledley, Fred D.

Volltext